Humacyte (HUMA) Other Working Capital Changes (2020 - 2025)
Humacyte (HUMA) reported Other Working Capital Changes of $968000.0 for Q4 2025, up 182.22% year-over-year from $343000.0 in Q4 2024, and up 1412.5% quarter-over-quarter from $64000.0 in Q3 2025.
Humacyte (HUMA) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Humacyte (HUMA) has 6 years of Other Working Capital Changes data on file, last reported at $968000.0 in Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at $968000.0, up 182.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $919000.0 (up 312.73% YoY), and the FY2025 annual result was $527000.0, up 1094.34% from the prior year.
- Other Working Capital Changes rose to $968000.0 in Q4 2025 per HUMA's latest filing, from $64000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.8 million in Q2 2023 and troughed at -$3.7 million in Q3 2023.
- A 5-year average of $61700.0 and a median of -$13500.0 in 2021 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes surged 6496.02% in 2021, then sank 11642.86% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $172000.0 in 2021, then plunged by 420.93% to -$552000.0 in 2022, then surged by 97.64% to -$13000.0 in 2023, then surged by 2738.46% to $343000.0 in 2024, then surged by 182.22% to $968000.0 in 2025.
- Business Quant data shows HUMA's Other Working Capital Changes at $968000.0 in Q4 2025, $64000.0 in Q3 2025, and -$113000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 968,000.00 |
| Dec 31, 2025 | 968,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Jun 30, 2025 | -113,000.00 |
| Mar 31, 2025 | -392,000.00 |
| Mar 31, 2025 | -392,000.00 |
| Dec 31, 2024 | 343,000.00 |
| Dec 31, 2024 | 343,000.00 |
| Sep 30, 2024 | -113,000.00 |
| Sep 30, 2024 | -113,000.00 |
| Jun 30, 2024 | -270,000.00 |
| Jun 30, 2024 | -270,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | -13,000.00 |
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | -3.70 Mn |
| Sep 30, 2023 | -3.70 Mn |